Main Session
Sep 29
SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials

242 - Intratumoral Heterogeneity of Mutational Drivers Associated with Radiation Response in Glioblastoma

01:20pm - 01:30pm ET

Presenter(s)

Taylor Weiskittel, MD, PhD, MS - Mayo Clinic, Scottsdale, AZ